University of Southern California
This study is a Stage III randomized trial to encourage patients in advance of a health care appointment to designate a healthcare proxy. Patients will be randomly assigned to receive a mailer containing information about designating a healthcare proxy, or to not receive any mailer. For patients assigned to receive a mailer, the mailer will differ by the presence or absence of a patient pre-commitment prompt, and contain a personalized provider request or a generic health system request. The work will evaluate the randomized trial and identify factors that predict intervention effectiveness.
Inclusion Criteria: * No EHR-documented healthcare proxy at enrollment * Age ≥ 55 years OR age ≥ 18 years and listed in the health system's cancer, CHF, or CKD registries Exclusion Criteria: * Primary care provider not assigned at time of randomization.
Patient mailers will ask the patient to name a healthcare proxy at their next primary care visit.
Patient mailers will be sent from and signed by the patient's provider for their next scheduled primary care visit.
Patient mailers will contain a box that asks the patient to bring a form with their choice for a healthcare proxy to their next primary care visit.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.